Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-27T19:51:11.444Z Has data issue: false hasContentIssue false
  • English
  • Français

Haematology

Published online by Cambridge University Press:  17 November 2008

Basil A Bradlow
Basil A Bradlow*
Affiliation:
University of Illinois at Chicago, USA
*
Basil A Bradlow, Department of Pathology, University of Illinois at Chicago, Chicago, Illinois 60680, USA.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 5 , Issue 1 , February 1995 , pp. 27 - 32
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Rochman, H. Clinical pathology in the elderly. Hematology. Basel: S Karger, AG, 1988: Chapter 18.Google Scholar
2 Mansourni, A, Lipschitz, DA. Anemia in the elderly patient. Med Clin North Am 1992; 76: 619–30.Google Scholar
3 Dalman, PR, Yip, R, Johnson, C. Prevalence and causes of anemia in the United States. Am J Clin Nutr 1984; 39: 437–45.Google Scholar
4 Koh, ET, Chi, MS, Lowerstein, FW. Comparison of selected blood components by race, sex and age. Am J Clin Nutr 1980; 33: 1828–35.CrossRefGoogle ScholarPubMed
5 Lipschitz, DA, Udupa, KP, Milton, KY, Thompson, CD. Effect of age on hemopoiesis in man. Blood 1984; 63: 502–509.CrossRefGoogle ScholarPubMed
6 Kario, K, Matsuo, T, Nakao, K. Serum erythropoietin levels in the elderly. Gerontology 1991; 37: 345–48.Google Scholar
7 Joosten, E, Pelemans, W, Hiele, M, Nogen, J, Verhaege, R, Boogaerts, MA. Prevalence and causes of anemia in a geriatric hospitalized population. Gerontology 1992; 38: 111–17.CrossRefGoogle Scholar
8 Rochman, H. Clinical pathology in the elderly. Iron. Basel: S Karger, AG, 1988: Chapter 5.Google Scholar
9 Means, RT, Krantz, SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80: 1639–47.CrossRefGoogle ScholarPubMed
10 Rochman, H. Clinical pathology in the elderly. Vitamin B12 and folate. Basel: S Karger, AG, 1988: Chapter 6.Google Scholar
11 Webster, SGP, Loeming, JT. Erythrocyte folate levels in young and old. J Am Geriatr Soc 1979; 27: 451–54.Google Scholar
12 Baker, H, Jaslow, SP, Frank, O. Severe impairment of dietary folate utilization in the elderly. J Am Geriatr Soc 1978; 26: 218–21.Google Scholar
13 Lindenbaum, J, Healton, EB, Savage, EB et al. Neuro-psychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720–28.CrossRefGoogle ScholarPubMed
14 Fine, EJ, Emilio, DS. Myths about vitamin B12 deficiency. South Med J 1991; 84: 1475–81.CrossRefGoogle ScholarPubMed
15 Stabler, SP, Allen, RH, Savage, DG, Lindenbaum, J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990; 76: 871–81.CrossRefGoogle ScholarPubMed
16 Yao, Y, Yao, SI, Yao, SS, Yao, G, Lou, W. Prevalence of vitamin B12 deficiency among geriatric patients. J Fam Pract 1992; 35: 524–28.Google Scholar
17 Norman, EJ, Morrison, JA. Screening elderly populations for cobalamin deficiency using the urinary methyl malonic acid assay by GCMS. Am J Med 1993; 94: 589–94.CrossRefGoogle Scholar
18 Blundell, EL, Mathews, JH, Allen, SM, Middleton, AM, Morris, JE, Wickramasinghe, SM. Importance of low serum vitamin B12 in elderly hospital patients. J Clin Pathol 1985; 38: 1179–84.CrossRefGoogle Scholar
19 Carmel, R, Sinow, RM, Siegel, ME, Sandoff, M. Food cobalamin malabsorption occurs frequently in patients with unexplained low serum cobalamin levels. Arch Intern Med 1988; 148: 1715–19.Google Scholar
20 Logan, RF, Elvis, A, Forrest, MJ, Lawrence, ACK. Mechanisms of vitamin B12 deficiency in elderly patients. Age Ageing 1989; 18: 4–10.CrossRefGoogle Scholar
21 Lokhorst, HM, van der Linden, JA, Schuurman, HJ et al. Immune function during aging in man: relation between serological abnormalities and cellular immune status. Eur J Clin Invest 1983; 13: 209–14.CrossRefGoogle ScholarPubMed
22 Thompson, JS, Wekstein, DR, Rhoades, JL et al. The immune status of healthy centenarians. J Am Geriatr Soc 1984; 32: 274–81.CrossRefGoogle ScholarPubMed
23 Wedelin, C, Bjorkholm, M, Holm, G, Ogenstad, S, Mellstedt, H. Blood T lymphocyte function in healthy adults in relation to age. Scand J Haematol 1982; 28: 45–53.CrossRefGoogle Scholar
24 Varga, Z, Bressani, W, Zaia, AM et al. Cell surface markers, inositol phosphate levels and membrane potential of lymphocytes from young and old human patients. Immunol Lett 1990; 23: 275–80.Google Scholar
25 Murasko, DM, Goonewardene, IM. T-cell function in aging: mechanisms of decline. Ann Rev Gerontol Geriatr 1990; 10: 71–96.Google Scholar
26 Rochman, H. Clinical pathology in the elderly. Hemostatis. Basel: Karger, AG, 1988: Chapter 19.Google Scholar
27 Hamilton, PJ, Allardyce, M, Ogston, D, Dawson, DA, Douglas, AS. The effect of age upon the coagulation system. J Clin Path 1974; 27: 980–82.Google Scholar
28 Johnson, M, Ramey, E, Ramwell, PW. Sex and age differences in human platelet aggregation. Nature 1975; 253: 355–57.CrossRefGoogle ScholarPubMed
29 Korsan-Bengtsson, K, Bengtsson, C, Tibblin, E. Blood coagulation, fibrinolysis and platelet function in women age 38 to 60 years. Acta Med Scand 1973; 193: 543–46.Google Scholar
30 Duncan, A, Didisheim, P. The influence of physiological parameters on the plasma concentration of B-thromboglobulin and platelet factor 4 in normal healthy subjects. Thromb Hemostasis 1981; 46: 28–33.Google Scholar
31 Briselli, MF, Ellman, L. The template bleeding time in elderly individuals. Thromb Hemost 1979; 42: 797–98.Google ScholarPubMed
32 Gough, KR. Capillary resistance to suction in hypertension. Br Med J 1962; i: 21–24.Google Scholar
33 Bowden, M, Crawford, J, Cohen, HI, Nogama, O. A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly. J Am Geriatr Soc 1993; 41: 11–14.CrossRefGoogle ScholarPubMed
34 Kyle, RA. Monoclonal gammopathy of undetermined significance (MGUS): a review. In: Hoffbrand, AV, Lasch, HG, Nathan, DG et al. eds. Clinical hematology, Volume 11. Eastbourne: WB Saunders, 1982: 123–50.Google Scholar
35 Ligthart, GJ, Rade, J, Corberand, JX et al. Monoclonal gammopathies in human aging. Increased occurrence with age and correlation with health status. Mech Ageing Dev 1990; 52: 235–43.Google Scholar
36 Kyle, RA. ‘Benign’ monoclonal gammopathy after 20 to 35 years to follow up. Mayo Clin Proc 1993; 68: 26–36.CrossRefGoogle Scholar
37 Kyle, RA. Monoclonal gammopathy of undetermined significance. Natural history of 241 cases. Am J Med 1978; 64: 814–26.Google Scholar
38 Durie, BGM, Salmon, SE. Multiple myeloma, macroglobuleminia and monoclonal gammopathies. In: Hoffbrand, AV, Brain, MC, Hirsh, J eds. Recent advances in hematology. Edinburgh: Churchill-Livingstone, 1977: 243.Google Scholar
39 Salmon, S, Cassady, JR. Plasma cell neoplasms. In: De Vita, VT, Hellman, S, Rosenburg, S eds. Cancer, principles and practice of oncology. Philadelphia: JB Lippincott, 1988: 1862.Google Scholar
40 Durie, BGM. Staging and kinetics of multiple myeloma. Semin Oncol 1986; 13: 300–309.Google Scholar
41 Grogan, TM, Spier, CM. The B cell immuno-proliferative disorders, including multiple myeloma and amyloidosis. Neoplastic hemato pathology. Baltimore: Williams and Wilkins, 1992: 1235–65.Google Scholar
42 Lichtman, M. Essential and secondary monoclonal gammopathies. In: Williams, WJ, Beutler, E, Ersler, AJ, Lichtman, MA eds. Hematology, fourth edition. New York: McGraw-Hill Inc, 1990: 1109–12.Google Scholar